We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 48

No more isolated DNA patents, the Supreme Court rules

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • June 13 2013

In a unanimous decision, the U.S. Supreme Court today ruled that naturally occurring, isolated human gene sequences are a product of nature, and thus

Bowman v. Monsanto: crisis averted on IP protection for self-replicating technologies

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • May 14 2013

Life science companies in general (and seed companies in particular) are breathing a sigh of relief following the Supreme Court's decision yesterday

A fractured Federal Circuit creates more questions than answers: CLS Bank Int’l v. Alice Corp., No. 2011-1301

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • May 13 2013

On Friday, the U.S. Court of Appeals for the Federal Circuit issued its en banc decision in CLS Bank Int'l v. Alice Corp. The decision includes seven

After Myriad oral argument, Supreme Court set to decide patentability of isolated human DNA molecules

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • April 15 2013

Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to

Australian Federal Court upholds Myriad’s gene patent

  • Morrison & Foerster LLP
  • -
  • Australia, USA
  • -
  • February 15 2013

While the question of patentability of isolated gene sequences awaits resolution at the U.S. Supreme Court, the Australian Federal Court today upheld

Beineke v. Kappos are discovered plants patentable?

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • January 28 2013

In November, Walter Beineke petitioned the Supreme Court for review of a Federal Circuit decision affirming the rejection of two plant patents on

New developments on the "patentable subject matter" requirement of U.S. patent law

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • January 16 2013

Two recent opinions by the Supreme Court of the United States ("Supreme Court") and the Court of Appeals of the Federal Circuit ("Federal Circuit"

District court decision opens door to additional patent term adjustment

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • January 15 2013

In Exelixis, Inc v Kappos a federal district court overturned the US Patent and Trademark Office's (USPTO) interpretation of the patent term

Myriad finally gets its day in (the Supreme) Court

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • November 30 2012

The Supreme Court today granted certiorari in Assoc. for Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (Myriad), to address the issue of whether human genes are patentable

Sound the alarm?The Supreme Court’s renewed interest in life sciences patents could create additional hurdles across the field

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • November 16 2012

First, there was Mayo v. Prometheus, where the Supreme Court found the medical diagnostic methods at issue were not patentable subject matter

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy